key: cord-0790870-jvog9dpj authors: Zhou, J.; Otter, J.; Price, J. R.; Cimpeanu, C.; Meno Garcia, D.; Kinross, J.; Boshier, P.; Mason, S.; Bolt, F.; Holmes, A. H.; Barklay, W. title: Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London date: 2020-05-26 journal: nan DOI: 10.1101/2020.05.24.20110346 sha: 09a79744211d48f663eb8ea11535dfa4aa42f6c2 doc_id: 790870 cord_uid: jvog9dpj Objectives: To evaluate SARS-CoV-2 surface and air contamination during the peak of the COVID-19 pandemic in London. Design: Prospective cross-sectional observational study. Setting: An acute NHS healthcare provider. Participants: All inpatient wards were fully occupied by patients with COVID-19 at the time of sampling. Interventions: Air and surface samples were collected from a range of clinical areas and a public area of the hospital. An active air sampler was used to collect three or four 1.0 m3 air samples in each area. Surface samples were collected by swabbing approximately 25 cm2 of items in the immediate vicinity of each air sample. SARS-CoV-2 was detected by RT-qPCR and viral culture using Vero E6 and Caco2 cells; additionally the limit of detection for culturing SARS-CoV-2 dried onto surfaces was determined. Main outcome measures: SARS-CoV-2 detected by PCR or culture. Results: Viral RNA was detected on 114/218 (52.3%) of surface and 14/31 (38.7%) air samples but no virus was cultured. The proportion of surface samples contaminated with viral RNA varied by item sampled and by clinical area. Viral RNA was detected on surfaces and in air in public areas of the hospital but was more likely to be found in areas immediately occupied by COVID-19 patients (67/105 (63.8%) in areas immediately occupied by COVID-19 patients vs. 29/64 (45.3%) in other areas (odds ratio 0.5, 95% confidence interval 0.2-0.9, p=0.025, Fishers exact test). The PCR Ct value for all surface and air samples (>30) indicated a viral load that would not be culturable. Conclusions: Our findings of extensive viral RNA contamination of surfaces and air across a range of acute healthcare settings in the absence of cultured virus underlines the potential risk from surface and air contamination in managing COVID-19, and the need for effective use of PPE, social distancing, and hand/surface hygiene. apart from the Emergency Department. In the part of the Emergency Department dedicated 1 3 9 for patients with confirmed or suspected COVID-19, two of the cubicles were occupied and 1 4 0 one patient was in the ambulatory wait area at the time of sampling. These areas were 1 4 1 disinfected daily using a combined chlorine-based detergent/disinfectant (Actichlor Plus, 1 4 2 Ecolab), with an additional twice daily disinfection of high touch surfaces using the same In each of these clinical areas, four air samples were collected (five air samples were 1 4 6 collected in the Emergency Department, and three in public areas of the hospital). Surfaces 1 4 7 in the immediate vicinity of each air sample that were considered to be touched frequently by 1 4 8 staff or patients were sampled. These included bed rails, clinical monitoring devices (blood 1 4 9 pressure monitors), ward telephones, computer keyboards, clinical equipment (syringe 1 5 0 pumps, urinary catheters), hand-cleaning facilities (hand washing basins, alcohol gel 1 5 1 dispensers). In each clinical area, sampling was performed in both patient (i.e. bays and 1 5 2 single rooms) and non-patient care areas (i.e.nursing stations and staff rooms). 1 5 3 Environmental sampling was conducted during three tracheostomy procedures. During the 1 5 4 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.24.20110346 doi: medRxiv preprint 7 first procedure, air sampling was performed before and during the procedure; for the other 1 5 5 procedures, air sampling was performed during the procedure only. Sampling methods 1 5 8 Air sampling was performed using a Coriolis μ air sampler (referred to as Coriolis hereafter) 1 5 9 (Bertin Technologies), which collects air at 100-300 litres per minute (LPM). After 10 min Dulbeccos's minimal essential medium (DMEM). Surface samples were collected by 1 6 2 swabbing approximately 25 cm 2 areas of each item using flocked swabs (Copan, US) sampling. In all clinical settings, samples were taken in order from the lowest to highest 1 6 5 perceived risk of SARS-CoV-2 contamination. 1 6 8 Viral RNA detection and absolute quantification was performed using quantitative real-time 1 6 9 reverse transcription polymerase chain reaction (RT-qPCR). Samples were extracted from manufacturer's instructions (Qiagen, Germany). Negative controls (water) were extracted 1 7 2 and included in the PCR assays. SARS-CoV-2 viral RNA was detected using AgPath-ID One-Step RT-PCR Reagents (Life Technologies) with specific primers and probes targeting 1 7 4 the envelop (E) gene. 15 The number of SARS-CoV-2 virus E gene copies per m 3 air and 1 7 5 copies per swab were calculated. All samples were run in duplicate. Viral culture: Vero E6 (African Green monkey kidney) and Caco2 (human colon carcinoma) 1 7 8 cells were used to culture virus from air and environmental samples. The cells were cultured 1 7 9 in DMEM supplemented with heat inactivated fetal bovine serum (10%) and 1 8 0 Penicillin/Streptomycin (10, 000 IU/mL &10, 000 µg/mL). For propagation, 200 µL of 1 8 1 samples were added to 24 well plates. After 5-7 days, cell supernatants were collected, and All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.24.20110346 doi: medRxiv preprint RT-qPCR to detect SARS-CoV-2 performed as described above. Samples with at least one 1 8 3 log increase in copy numbers for the E gene (reduced Ct values relative to the original 1 8 4 samples) after propagation in cells were considered positive by viral culture. We defined samples where both of the PCRs performed from an air or surface sample 1 8 7 detected SARS-CoV-2 RNA as positive, and samples where one of the two PCRs performed 1 8 8 from an air or surface sample detected SARS-CoV-2 RNA as suspected. We performed a laboratory experiment to determine the limit of detection for culturing SARS- CoV-2 dried on surfaces. A dilution series from solution containing 8.25x10 6 PFU/mL SARS- CoV-2 (titred by plaque assay in Vero cells) from 10 -3 to 10 -6 (covering Ct values from 26 to 1 9 3 36) was produced in DMEM and 50 µL inoculated in triplicate onto the surface of plastic 1 9 4 (standard keyboard key) or stainless steel (2 x 1 x 0.2 cm) pieces. The inoculated surfaces 1 9 5 were dried in a safety cabinet for 2 hours after which they were visibly dry. They were then 1 9 6 sampled using flocked swabs. Swabs were deposited into 1.5 mL of DMEM for 1 hour. RT- 1 9 7 qPCR was used to determine viability following 7 days of culture as follows. 140 µL was 1 9 8 used for RNA extraction and qPCR immediately (0 days post inoculation, dpi) and after 1 9 9 incubation for 7 days in a 24-well plate with VeroE6 cells (7 dpi). Samples with an increase surface contamination in each of the areas was log transformed and then compared by one- (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The work was registered locally as an NHS service evaluation (#434). (10.6%)) for SARS-CoV-2 RNA but no virus was cultured ( Table 1 ). The proportion of identified on >80% of computer keyboards/mice, alcohol gel dispensers, and chairs, and >50% (38.7%)) or positive 92/31 (6.4%)) for SARS-CoV-2 RNA (Table 1 ). ranging from 10 1 to 10 3 genome copies / m 3 (Table 1) ; there was no significant difference in CoV-2 RNA was detected in surface samples from all eight areas tested, with levels ranging 2 2 7 from 10 1 to 10 4 copies per swab ( Figure 2 ). There was a significant difference in the mean Ward A and the Temporary CPAP ward showing higher levels of viral RNA; Cohort Ward A 2 3 0 (mean = 1.76 log 10 copies/swab) > Adult ICU (mean = 0.0018 log 10 copies/swab) (p = 0.015), where aerosol generating procedures are commonly performed (although had not been 2 3 6 performed for more than two hours prior to sample collection). In a ward temporarily 2 3 7 converted for CPAP, SARS-CoV-2 RNA was detected from air within the negative pressure All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.24.20110346 doi: medRxiv preprint 1 0 CPAP bay, and outside the bay. No patient was undergoing CPAP at the time of sampling, 2 3 9 but one patient was undergoing high-flow nasal cannula (HFNC) oxygen therapy. In the nursing station outside of the CPAP unit, and in the hospital main entrance and public toilets. However, positive or suspected air and surface samples were significantly more likely to be areas (odds ratio 0.5, 95% confidence interval 0.2-0.9, p=0.025). Since viable virus was not cultured from any of the air or surface samples, we performed dried surfaces with a Ct value <30; this was consistent for plastic and metal test surfaces (Table 2 ). In our study, all surface and air samples from the hospital environment had a Ct SARS-CoV-2 RNA was detected frequently from surface and air samples but we did not studies showed that the RNA levels detected on environmental surfaces in the hospital were lower than the minimum that can be cultured from surfaces two hours after virus is 2 6 4 deposited. SARS-CoV-2 RNA was identified across the eight areas that we tested, including 2 6 5 areas of the hospital not used to care for patients with COVID-19 (e.g. public areas of the All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.24.20110346 doi: medRxiv preprint 1 1 hospital). However surface and air contamination was significantly more frequent in areas 2 6 7 immediately occupied by COVID-19 patients than in other areas. A direct comparison between our findings and other studies that have evaluated 2 7 0 contamination of surfaces and air with SARS-CoV-2 is not possible due to differences in: including the stage and severity of disease and site of infection, which have been shown to 2 7 7 influence shedding of SARS-CoV-2 and other hospital pathogens; 4 16 and the patient and detection of viral RNA on surfaces (114/218, 52.3%) and to a lesser extent air (14/31, surface and air samples positive for viral RNA is higher in our study. [8] [9] [10] [11] [12] [13] For example, Ye et contamination of surfaces or air. 8 10 Other studies have observed higher frequencies of 2 8 7 contamination in patient-care vs. non-patient-care areas, 8 9 11 and variation in the frequency surprising finding in our study was that the level of contamination on surfaces in the ICU was 2 9 0 lower than in a cohort general ward or in the temporary CPAP ward, in contrast to other findings. 9 This may be because most patients in the ICU are on closed ventilation systems, which may have a lower risk of producing surface and air contamination than some other All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We did not identify viable virus on any surface or air sample. To our knowledge, only one 2 9 6 other study has attempted to culture SAR-CoV-2 from healthcare environments, and no 2 9 7 viable virus was detected. 10 Our laboratory study of the viability of virus dried on surfaces 2 9 8 helps to qualify our findings and the findings of others, suggesting that Ct values of >30 are 2 9 9 unlikely to be culturable. Bearing in mind that the viral RNA detected in the hospital setting 3 0 0 might have been deposited more than two hours previously, we cannot differentiate whether Surface contamination was detected on a range of items. Computer keyboards, chairs, and Other studies have also identified computer keyboards and/or mice as a risk for contamination with SARS-CoV-2 RNA. 8 9 11 Many of the computers that we sampled were in of these items. The contamination of alcohol gel dispensers is unsurprising since staff hands 3 1 0 activate these before hand hygiene is performed. However, alcohol gel dispensers should be We sampled several areas where aerosol generating procedures are commonly performed 3 1 4 including the resuscitation bay in the emergency department, ICU, temporary CPAP ward, 3 1 5 and operating theatres during tracheostomies. Positive or suspected air samples were 3 1 6 identified in all of these clinical areas at a level of 10 1 to 10 3 copies / m 3 . There was no 3 1 7 difference in the viral load of the air across the eight areas sampled, which provides some 3 1 8 evidence that AGPs do not produce persistently high levels of air contamination. However, 3 1 9 we did not sample the air over time, and our air sampling method did not differentiate 3 2 0 particle size so we are unable to distinguish droplets from aerosols (< 5 µM). One recent All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. identified a low levels (in the 10 1 -10 2 range copies per m 3 ) in patient care areas, and was not 3 2 4 detected or detected in very low levels in public areas. Positive samples were identified in a 3 2 5 range of particle sizes, including those <5 µM, which would typically be considered as 3 2 6 aerosols. 2 It seems likely, therefore, that the positive and suspected air samples identified in 3 2 7 our study included a range of particle sizes spanning 5 µM, particularly in areas where 3 2 8 aerosol generating procedures are common. Whilst we performed sampling in a temporary CPAP ward, no patient was undergoing CPAP sample, and air contamination was identified <1 m from this patient. A recent summary of 3 3 3 evidence concludes that HFNC is a lower risk procedure in terms of aerosol generation than 3 3 4 CPAP, which should be a topic for future studies. 17 We identified contamination of surfaces and air during three tracheostomy procedures. Several studies and commentaries have evaluated the potential for various surgical 3 3 8 procedures to produce aerosols for patients with COVID-19. [18] [19] [20] One study evaluated the 3 3 9 spread of droplets during tracheostomies, although did not include sampling for SARS-CoV- 2. 18 Whilst our methods did not include measurement of particle size, our findings highlight a Our study has important strengths and limitations. Strengths include our sampling strategy including both patient care and non-patient care areas, specifically, we included operating 3 4 7 theatres and areas dedicated to known and potential AGPs; each sample was tested using 3 4 8 PCR and also viral culture, and we performed laboratory viral culture experiments to quality 3 4 9 our findings; the sampling was conducted during the peak of the pandemic (and so likely 3 5 0 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.24.20110346 doi: medRxiv preprint 1 4 represents a worst-case scenario) in a European hospital group. Limitations include not 3 5 1 collecting patient samples to better understand how our findings links to patient samples, 3 5 2 particularly during tracheostomies and AGPs; no asymptomatic patient or staff testing 3 5 3 ongoing at the time of sampling, which means patients and staff without known COVID-19 3 5 4 could have been shedding SARS-CoV-2 and this would explain the detection of SARS-CoV- 2 RNA in non-patient care areas; challenges in interpreting the significance of samples with 3 5 6 low viral loads, ; a lack of resolution of particle sizes for contamination of the air; and no 3 5 7 longitudinal sampling was performed so these findings represent a "snapshot". (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Can we contain the COVID-19 outbreak with the same measures as for SARS? Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination SARS Transmission and Hospital Containment Temporal dynamics in viral shedding and transmissibility of COVID-19 Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 Stability of SARS-CoV-2 in different environmental conditions Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019 No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted Environmental contamination of SARS-CoV-2 in healthcare premises SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR The role played by contaminated surfaces in the transmission of nosocomial pathogens No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted High-flow nasal cannula for COVID-19 patients: low risk of bioaerosol dispersion Tracheostomy during COVID-19 pandemic-Novel approach Clinical evidence based review and recommendations of aerosol generating medical procedures in otolaryngology -head and neck surgery during the COVID-19 pandemic Overview of guidance for endoscopy during the coronavirus disease 2019 pandemic Facial protection for healthcare workers during pandemics: a scoping review Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal Endoscopic Skull Base and Transoral Surgery During the COVID-19 Pandemic: Minimizing Droplet Spread with a Negative-Pressure Otolaryngology Viral Isolation Drape (NOVID) COVID-19 coronavirus: recommended personal protective equipment for the orthopaedic and trauma surgeon COVID-19 supports the need for enhanced disinfection. Social distancing is recommended 3 6 5 by most governments and personal protective equipment (PPE) is recommended during 3 6 6 contact with patients with COVID-19 plus higher levels of PPE for performing aerosol 3 6 7 generating procedures. Whilst we did not measure particle sizes during our air sampling, our 3 6 8 findings highlight a potential role for contaminated air in the spread of COVID-19. Our finding 3 6 9 of air contamination outside of clinical areas should be considered when making respiratory Whilst SAR-CoV-2 RNA was detected within healthcare environments, further research linking patient, staff and environmental samples is required to better understand 3 7 4 transmission routes. Longitudinal environmental and clinical sampling across healthcare 3 7 5 settings is required to understand risk factors associated with viral shedding and 3 7 6 transmission. Our findings can be used to parameterise mathematical models of COVID-19 3 7 7 transmission. Finally, our methods can be used to assess the potential risk associated with 3 7 8 All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.24.20110346 doi: medRxiv preprint 1 5 various procedures including some surgical and other procedures such as CPAP and 3 7 9 nebulisation of medications. Findings from these studies may prompt changes to PPE 3 8 0 recommendations for specific procedures, and the implementation of various innovative 3 8 1 tools and approaches to reduce viral shedding (such as "helmet CPAP"). 22 contamination of surfaces and air across a range of acute healthcare settings in the absence 3 8 7 of cultured virus underlines the potential risk from surface and air contamination in managing 3 8 8 COVID-19, and the need for effective use of PPE, social distancing, and hand/surface 3 8 9 hygiene. We wish to acknowledge the staff teams and patients who supported this sampling during All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.24.20110346 doi: medRxiv preprint All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.24.20110346 doi: medRxiv preprint 2 4 All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020.05.24.20110346 doi: medRxiv preprint